Navigation Links
Human Primary Preadipocytes and Differentiated Adipocytes


Human Primary Preadipocytes and Differentiated Adipocytes

A new paradigm for energy metabolism research

Yuan-Di C. Halvorsen
Zen-Bio, Inc.

Peter Pingerelli Matt C. Petre
Stratagene

Regis Saladin
Ligand Pharmaceuticals

Michael R. Briggs
SmithKline Beecham Pharmaceuticals

Stratagene introduces new tools to facilitate the study of human adipocyte biology: Human Predifferentiated Adipocytes and Human Differentiated Adipocytes. Adipose tissue is a differentiated endocrine organ that primarily functions to manage energy homeostasis. Human primary adipocytes represent a model system to study these complex processes. The stromal-vascular fraction from adipose tissue can be processed to isolate preadipocytes and induced with hormones to differentiate into adipocytes. The resulting in vitro differentiated cells are functionally similar to primary human adipocytes and can be cultured for weeks without loss of adipocyte-specific markers, unlike the fragile primary adipocytes that die within 24 hours.

The study of adipocyte biology is important not only to understand metabolic diseases (including obesity, diabetes, dyslipidemia, and atherosclerosis), but to develop pharmacological agents to treat such maladies. Adipose tissue is critical for maintaining energy balance, because it serves both as a storage depot and an endocrine organ.1 It is actively involved in sensing the nutritional state of the organism through several different signaling pathways. It responds by altering the expression of genetic pathways to mobilize or store energy and activating signals to other tissues to regulate energy balance.

Previously, all research in adipocyte biology was conducted using rodent cells, mainly transformed cell lines.2 However, because humans and rodents have distinct genetic backgrounds and metabolic pathways, potential experimental pitfalls were inevitable. For example, compounds effective in activating the b3-adrenergic pathway in rodents failed to stimulate human adipocytes to burn more fat.3 Stratagene now offers Human Predifferentiated Adipocytes and Human Differentiated Adipocytes, so rodent systems can be bypassed for human systems in experiments involving adipocyte signal transduction pathways or gene regulation.

Human Preadipocyte Differentiation

When excess preadipocytes are recruited into the differentiated adipocyte, obesity results. Since from adolescence through adulthood humans continue to recruit cells to become adipocytes, it is of interest to study the environmental and humoral factors that initiate and maintain the differentiated phenotype of adipocytes. Human preadipocytes provide the tools to explore the most relevant factors that influence human obesity.

Stratagene recently developed the Adipocyte Differentiation Kit, which uses a simple and efficient method to differentiate human primary preadipocytes into mature, fully functional adipocytes. Undifferentiated preadipocytes are cultured in DMEM/F-10 (1:1, v/v) with 10% fetal bovine serum. The cells can be passaged for expansion, frozen for later reuse, or differentiated. The absence of staining with antisera to factor VIII and lack of vascular endothelial growth factor receptor mRNA, shown by Northern analysis, 4 demonstrated that no endothelial cells are present in the preadipocyte culture.

Earlier passage cells are more robust in both growth and differentiation potential; passages one to three are ideal. Stratagene uses only passage-two human preadipocytes for the Adipocyte Differentiation Kit. Typically, a production lot of cells is isogenic, and lots vary within the 10% to 20% range for total differentiation potential, as measured by lipid accumulation.

Up to 90% of the Human Predifferentiated Adipocytes can be induced to differentiate after they have been treated with a hormone and chemical cocktail. This treatment promotes a cascade of transcription factors activation and adipocyte-specific gene expression that leads to the mature adipocyte phenotype (Figure 1, panel A and B). Predifferentiated Adipocyte Differentiation Medium is also available from Stratagene as a separate reagent.

Figure 1

During the differentiation process5, key adipocyte- specific genes, such as PPARg, fatty acid binding protein, and obese gene, are expressed.6,7,8 Expression of signaling molecules, such as leptin, the obese gene product is induced during differentiation (Figure 2).

Figure 2

Practical Applications

By using Stratagenes Human Predifferentiated Adipocytes, various questions can be addressed: What makes these cells differentiate from fibroblast-like cells to adipocytes? What are adipocytes similarities and differences? What chemical and endocrine effectors transform preadipocytes? What gene expression changes are necessary and/or sufficient for preadipocyte transformation?

Human Predifferentiated Adipocytes are available in a 24- or 96-well format and are shipped ready to use. Besides providing a unique tool to study the processes that trigger and promote differentiation, these cells can be used to identify agents that block or slow the differentiation process.

Human Adipocyte-Specific Gene Expression

By characterizing gene expression and regulation, we may unravel the mysteries of the adipocytefrom its role as an endocrine receptor to its role as a mediator of energy homeostasis. Transfection experiments, which lead to overexpression of wild type or mutated protein forms, are used to characterize many gene functions. The phenotype of the altered expression state allows the effects of single gene changes to be examined, which may model metabolic derangement associated with particular diseases.9

To date we have successfully transfected Human Differentiated Adipocytes with the human adipose- specific obese gene and peroxisome proliferator activated receptor gamma (PPARg) gene promoter-driven reporters (data not shown). In experiments to improve the transfectability of Human Differentiated Adipocytes or Human Predifferentiated Adipocytes using Stratagenes Transfection MBS Mammalian Transfection Kit or LipoTAXI Transfection Reagent, respectively, we showed that including the Primary Transfection ENHANCER results in a higher transfection efficiency (Figure 3, panel A and panel B).

Figure 3

Lipolysis: A Differentiated Adipocyte Process

One of the key functions of adipocytes is to adjust lipid storage according to the physiological energy needs of the organism. When extra calories are required, adipocyte intracellular triglyceride stores are metabolized to glycerol and fatty acids for further oxidation, a process termed lipolysis.10 Our Human Differentiated Adipocytes respond to adrenergic hormone receptor agonists, such as norepinephrine or isoproterenol, to induce this metabolic pathway. The lipolysis response can be assayed by measuring the release of glycerol into the culture medium (Figure 4). Thus, these cells are useful for analyzing compounds or genes that induce, or are involved with, this important function of the mature adipocyte.

Figure 4

Conclusions

With Stratagenes new Human Predifferentiated Adipocytes and Human Differentiated Adipocytes, researchers have a new class of reagents with which to study human adipose biology. It is now possible to directly study the factors that affect human adipose differentiation, and to identify agents which may promote or interfere with the progression of obesity. Gene expression in both adipocytes and preadipocytes can be achieved with the aid of Primary Transfection ENHANCER, a new reagent developed by Stratagene to enhance primary cell transfection.

REFERENCES
  1. Flier, J. (1995) Cell 80: 15-18.

  2. Green, H. and Kehinde, O. (1975) Cell 5: 19-27.

  3. Arch, J.R.S. and Wilson, S. (1996) Int. J. Obes. 20: 191-199.

  4. Claffey, K. and Halvorsen, Y.C. unpublished results.

  5. Halvorsen, Y. C. unpublished results.

  6. Lehmann, J.M., et al. (1995) J. Clin. Invest. 270: 12953-12956.

  7. Tontonoz, P. Hu, E. and Spiegelman, B.M. (1994) Cell 79: 1147-1156.

  8. Brun, R.P., et al. (1996) Genes and Develop. 10: 974-984.

  9. Fraser, J.D., et al. (1997) J. Biol. Chem. 272: 1 3892-13898.

  10. Chernick, S., et al. (1986) J. of Lipid Res. 27: 286-294.


'"/>

Source:


Page: All 1 2 3 4 5 6

Related biology technology :

1. Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
2. Control RT-PCR Primers for Human Gene Transcripts with Varying Abundance
3. New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence Humanized Renilla GFP Reporter
4. Human Universal cDNA Library Array I
5. Map and Link Human Genetic Disorders with SSLP Analysis
6. RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes
7. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
8. Fluorescence-Based Single-Tube Assays to Rapidly Detect Human Gene Mutations
9. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
10. Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression Vector
11. Stratagenes Human cDNA Microarrays: Perform Gene Expression Profiling and Discover New Genes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: SVA), a leading provider ... that its board of directors has amended its shareholder rights plan. The ... 2017 to March 27, 2018. The amendment was not in response to ... ... Ltd. is a China -based biopharmaceutical company that ...
(Date:3/23/2017)... ... ... to announce it has become the premiere team-building cooking event company in San Diego. ... as Illumina, HP and Qualcomm, and is ranked #1 in its category on Trip Advisor. ... new team building format, a way for teams to not only interact with one another ...
(Date:3/23/2017)... MENLO PARK, Calif., March 23, 2017  BioPharmX ... developing products for the dermatology market, today reported ... Jan. 31, 2017, and will provide an update ... from the year. "We are pleased ... productive year for BioPharmX," said President Anja Krammer. ...
(Date:3/23/2017)... Colo. , March 23, 2017  Agriculture technology ... Series A financing and note conversion to commercialize its ... Planet is focused on developing products that are simultaneously ... $30 million in the last 18 months. This latest ... North Bridge Venture Partners. The company,s ...
Breaking Biology Technology:
(Date:3/22/2017)... March 21, 2017   Neurotechnology , a ... technologies, today announced the release of the ... provides improved facial recognition using up to 10 ... single computer. The new version uses deep neural-network-based ... and it utilizes a Graphing Processing Unit (GPU) ...
(Date:3/22/2017)... LIVERMORE, Calif. , March 21, 2017 ... recognition analytics company serving law enforcement agencies, announced today ... Sheridan as director of public safety business development. ... of diversified law enforcement experience, including a focus on ... Vigilant. In his most recent position, Mr. Sheridan served ...
(Date:3/20/2017)... , March 20, 2017 PMD Healthcare ... personal spirometer and Wellness Management System (WMS), a remote, ... Founded in 2010, PMD Healthcare is a Medical Device, ... a mission dedicated to creating innovative solutions that empower ... With that intent focus, PMD developed the first ever ...
Breaking Biology News(10 mins):